Hanmi Receives Domestic Patent for Novel Antibiotic Production Method

Published: 2004-12-31 06:57:00

Updated: 2004-12-31 06:57:00

Hanmi Pharmaceutical announced on December 29th that it has received a domestic patent on its novel production method for cefdinir, an oral antibiotic in the cephalosporin family of antibiotics.

According to the announcement, Hanmi made an investment of 1.6 billion won to develop the product...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK